DUBLIN--(BUSINESS WIRE)--The "Apheresis Market Growth, Analysis - Segmented by Product (Devices and Disposables), Procedure, Application and Geography - Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The apheresis market was valued at USD 1,788 million in 2017 and is expected to register a CAGR of about 10.89% during the forecast period 2018-2023.
Key Highlights
- Increasing Global Disease Burden Drives the Apheresis Market
- High Capital Investment and Cost Associated With Apheresis Procedures Acts as a Major Barrier for the Apheresis Market
- North America Expected to Have Largest Market Share in Apheresis Market
Market Segmentation Insights
- By product, the disposables have the largest share in the market which is 56% in 2017.
- By procedure, plasmapheresis has the largest share in the market.
- By technology, centrifugation has the highest share in the segment.
- By application, neurological disorders has the largest share in the market.
Developments in the Market
- MedAware Systems, Inc launched a comprehensive database on apheresis through its SOHInfo division, carrying data from clinical trials, cohort studies, medical journals and others.
Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Major Players
- Asahi Kasei Kuraray Medical Co. Ltd.
- B. Braun Melsungen AG
- Fenwal Inc.
- Haemonetics Corp.
- Hemacare Corporation
- Terumo BCT Inc.
- Therakos Inc.
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/lx42zw/worldwide?w=4
